"Disease-Free Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.
| Descriptor ID |
D018572
|
| MeSH Number(s) |
E01.789.200 E05.318.740.998.300 N05.715.360.750.795.300 N06.850.520.830.998.300
|
| Concept/Terms |
Disease-Free Survival- Disease-Free Survival
- Disease Free Survival
- Event-Free Survival
- Event Free Survival
- Event-Free Survivals
- Survival, Event-Free
- Survivals, Event-Free
- Survival, Disease-Free
- Disease-Free Survivals
- Survival, Disease Free
- Survivals, Disease-Free
Progression-Free Survival- Progression-Free Survival
- Progression Free Survival
- Progression-Free Survivals
- Survival, Progression-Free
- Survivals, Progression-Free
|
Below are MeSH descriptors whose meaning is more general than "Disease-Free Survival".
Below are MeSH descriptors whose meaning is more specific than "Disease-Free Survival".
This graph shows the total number of publications written about "Disease-Free Survival" by people in this website by year, and whether "Disease-Free Survival" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 5 | 5 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 5 | 5 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 8 | 8 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 4 | 4 |
| 2003 | 0 | 8 | 8 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 9 | 9 |
| 2006 | 0 | 19 | 19 |
| 2007 | 0 | 10 | 10 |
| 2008 | 0 | 10 | 10 |
| 2009 | 0 | 8 | 8 |
| 2010 | 0 | 11 | 11 |
| 2011 | 0 | 11 | 11 |
| 2012 | 0 | 23 | 23 |
| 2013 | 1 | 21 | 22 |
| 2014 | 0 | 30 | 30 |
| 2015 | 0 | 18 | 18 |
| 2016 | 0 | 24 | 24 |
| 2017 | 0 | 24 | 24 |
| 2018 | 0 | 13 | 13 |
| 2019 | 0 | 9 | 9 |
| 2020 | 0 | 8 | 8 |
| 2021 | 0 | 3 | 3 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease-Free Survival" by people in Profiles.
-
Postibrutinib relapse outcomes for patients with marginal zone lymphoma. Blood Adv. 2023 01 10; 7(1):88-91.
-
Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. J Clin Invest. 2021 10 01; 131(19).
-
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer. 2021 08 15; 127(16):2954-2965.
-
Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer. JAMA Netw Open. 2021 04 01; 4(4):e216322.
-
TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients. Aging (Albany NY). 2020 11 11; 12(21):21544-21558.
-
Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma. Ann Thorac Surg. 2021 10; 112(4):1067-1075.
-
Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Clin Cancer Res. 2021 01 01; 27(1):226-236.
-
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH. Am J Hematol. 2021 01; 96(1):E5-E8.
-
Interpreting Breast Cancer Survival Data by the Hazard Function: Remarkable Findings from Event Dynamics. Medicina (Kaunas). 2020 Sep 12; 56(9).
-
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer. Cancer Treat Res Commun. 2020; 24:100193.